-
1 Comment
Beijing Tong Ren Tang Chinese Medicine Company Limited is currently in a long term uptrend where the price is trading 27.5% above its 200 day moving average.
From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.1.
Beijing Tong Ren Tang Chinese Medicine Company Limited's total revenue rose by 22.6% to $748M since the same quarter in the previous year.
Its net income has increased by 59.9% to $316M since the same quarter in the previous year.
Finally, its free cash flow fell by 76.1% to $27M since the same quarter in the previous year.
Based on the above factors, Beijing Tong Ren Tang Chinese Medicine Company Limited gets an overall score of 4/5.
| CurrencyCode | HKD |
|---|---|
| ISIN | HK0000145638 |
| Exchange | HK |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Beta | 0.4 |
|---|---|
| Dividend Yield | 2.3% |
| Target Price | 15.55 |
| PE Ratio | 22.15 |
| Market Cap | 12B |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 3613.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
